2884
Y. Urawa et al.
SPECIAL TOPIC
dard. HRMS spectra were obtained on a Micromass Q-Tof Ultima
global.
13C NMR (CDCl3): = 12.92, 14.68, 127.30, 132.65, 132.88,
137.42, 137.49, 143.41, 189.8.
HRMS (ESI): m/z calcd for C9H11OS [MH]+: 167.0531; found:
167.0541.
(E)-2-Methyl-1-phenylbut-2-en-1-one (Entry 1, Table 1); Typi-
cal Procedure
To a mixture of phenylboronic acid (1; Ar = Ph, 146 mg, 1.20
mmol), (Ph3P)2PdCl2 (14.0 mg, 0.02 mmol) and hydrated K3PO4
(286 mg, 1.20 mmol) in toluene (4 mL) under N2 was added tigloyl
chloride (2; R1 = R3 = Me, R2 = H, 119 mg, 1.00 mmol) by syringe.
The reaction mixture was heated at 80 °C for 4 h. After removal of
the insolubles by filtration, purification of the filtrate by silica gel
column chromatography (hexane–EtOAc, 100:1) gave the corre-
sponding product (158 mg, 99%); colorless oil (Table 1).
3-Methyl-1-phenylbut-2-en-1-one (Entry 6, Table 1)
IR (neat): 2912, 1660, 1614, 1247, 1011, 700 cm–l.
1H NMR (CDCl3): = 2.01 (d, 3 H, J = 1.0 Hz), 2.20 (d, 3 H, J = 1.2
Hz), 6.74 (t, 3 H, J = 1.2 Hz), 7.42–7.45 (m, 2 H), 7.50–7.54 (m, 1
H), 7.91–7.94 (m, 2 H).
13C NMR (CDCl3): = 21.22, 28.01, 121.11, 128.07, 128.17,
128.32, 129.95, 132.16, 139.15, 156.52, 191.35.
IR (neat): 2924, 1647, 1276, 704 cm–l.
HRMS (ESI): m/z calcd for C11H12ONa [MNa]+: 188.0786; found:
1H NMR (CDCl3): = 1.88 (dq, 3 H, J = 1.5, 6.6 Hz), 1.97 (m, 3 H),
6.41 (qq, 1 H, J = 7.0, 1.5 Hz), 7.38–7.44 (m, 2 H), 7.46–7.52 (m,
1 H), 7.58–7.63 (m, 2 H).
13C NMR (CDCl3): = 12.29, 14.92, 127.84, 129.02, 131.06,
137.48, 138.64, 141.37, 198.61.
HRMS (ESI): m/z calcd for C11H13O [MH]+: 161.0966; found:
161.0972.
188.0788.
2-Methyl-1-phenylpropenone (Entry 7, Table 1)
IR (neat): 3063, 1656, 1332, 1199, 710 cm–l.
1H NMR (CDCl3): = 2.07 (dd, 3 H, J = 1.5, 6.6 Hz), 5.63 (m, 1 H),
5.91–5.92 (m, 1 H), 7.41–7.46 (m, 2 H), 7.51–7.56 (m, 1 H), 7.71–
7.78 (m, 2 H).
13C NMR (CDCl3): = 18.78, 126.96, 127.00, 128.0, 128.58,
129.25, 131.84, 137.53, 143.56, 198.05.
HRMS (ESI): m/z calcd for C10H11O [MH]+: 147.081; found:
147.0819.
(E)-2-Methyl-1-(4-methylphenyl)but-2-en-1-one (Entry 2, Ta-
ble 1)
IR (neat): 2923, 1646, 1607, 827, 739 cm–l.
1H NMR (CDCl3): = 1.87(d, 3 H, J = 6.8 Hz), 1.97 (s, 3 H), 2.40
(s, 3 H), 6.35–6.40 (m, 1 H), 7.21 (d, 2 H, J = 7.6 Hz), 7.53 (d, 2 H,
J = 7.6 Hz).
13C NMR (CDCl3): = 12.47, 14.80, 21.63, 128.52, 129.29, 135.76,
137.44, 140.25, 141.66, 198.42.
HRMS (ESI): m/z calcd for C12H15O [MH]+: 175.1123; found:
175.1151.
1-Phenylpropenone (Entry 8, Table 1)
IR (neat): 3060, 1684, 1598, 1449, 1104 cm–l.
1H NMR (CDCl3): = 5.94 (dd, 1 H, J = 1.7, 10.6 Hz), 6.44 (dd, 1
H, J = 1.7, 17.1 Hz), 7.16 (dd, 1 H, J = 10.5, 17.1 Hz), 7.49 (m, 2
H), 7.58 (tt, 1 H, J = 2.2, 7.3 Hz), 7.95 (m, 2 H).
13C NMR (CDCl3): = 128.54, 128.62, 130.12, 132.30, 132.91,
137.18, 190.93.
HRMS (ESI): m/z calcd for C9H8ONa [MNa]+: 155.0473; found:
155.0477.
(E)-2-Methyl-1-(3-methylphenyl)but-2-en-1-one (Entry 3, Ta-
ble 1)
IR (neat): 2923, 1647,1281, 796, 729 cm–l.
1H NMR (CDCl3): = 1.88 (dq, 3 H, J = 6.8, 1.0 Hz), 1.96 (m, 3 H),
2.39 (s, 3 H), 6.40 (qq, 1 H, J = 6.8, 1.5 Hz), 7.28–7.32 (m, 2 H),
7.36–7.40 (m, 1 H), 7.41–7.43 (m, 1 H).
(E)-1,3-Diphenylprop-2-en-1-one (Entry 9, Table 1)
IR (neat): 3060, 1664, 1606, 1450, 1216, 1017, 747 cm–l.
1H NMR (CDCl3): = 7.41–7.45 (m, 3 H), 7.49–7.64 (m, 4 H),
13C NMR (CDCl3): = 12.30, 14.90, 21.48, 126.24, 127.63, 129.46,
131.79, 137.55, 137.66, 138.70, 141.15, 198.84.
HRMS (ESI): m/z calcd for C12H15O [MH]+: 175.1123; found:
7.64–7.67 (m, 2 H), 7.82 (d, J = 15.9 Hz, 1 H), 8.02–8.04 (m, 2 H).
13C NMR (CDCl3): = 121.93, 128.30, 128.35, 128.48, 128.81,
130.40, 132.64, 134.70, 138.01, 144.68, 190.29.
HRMS (ESI): m/z calcd for C15H13O [MH]+: 209.0966; found:
175.1161.
209.0963.
(E)-2-Methyl-1-(2-methylphenyl)but-2-en-1-one (Entry 4, Ta-
ble 1)
2-[(E)-2-Methylbut-2-enoyl]benzonitrile (Equation 4)
IR (neat): 2926, 1654, 1639,1292, 127, 1977, 888, 734 cm–l.
IR (neat): 2927, 2229, 1654, 1637, 1295, 760 cm–l.
1H NMR (CDCl3): = 1.84 (dq, 3 H, J = 6.8, 1.0 Hz), 1.95 (m, 3 H),
2.24 (s, 3 H), 6.34 (qq, 1 H, J = 6.8, 1.2 Hz), 7.13–7.20 (m, 3 H),
7.27–7.31 (m, 1 H).
13C NMR (CDCl3): = 11.01, 15.18, 19.61, 124.83, 127.21, 128.96,
130.30, 135.34, 138.97, 139.72, 143.90, 200.55.
HRMS (ESI): m/z calcd for C12H15O [MH]+: 175.1123; found:
175.1105.
1H NMR (CDCl3): = 1.92 (dq, 3 H, J = 1.5, 6.6 Hz), 2.00 (m, 3
H,), 6.35 (qq, 1 H, J = 6.8, 1.2 Hz), 7.49 (dt, 1 H, J = 7.6, 0.7 Hz),
7.55 (dt, 1 H, J = 1.2, 7.6 Hz), 7.63 (dt, 1 H, J = 1.2, 7.6 Hz), 7.73
(dt, 1 H, J = 7.6, 1.2 Hz).
13C NMR (CDCl3): = 11.42, 15.40, 111.20, 116.96, 128.77,
129.99, 131.95, 133.17, 138.30, 143.27, 145.34, 195.60.
HRMS (ESI): m/z calcd for C12H12NO [MH]+: 186.0919; found:
186.0874.
(E)-2-Methyl-1-(2-thienyl)but-2-ene-1-one (Entry 5, Table 1)
IR (neat): 3100, 2923, 1626, 1416, 1283, 861, 829, 727 cm–l.
Acknowledgment
1H NMR (CDCl3): = 1.90 (dq, 3 H, J = 7.2, 1.2 Hz), 1.96 (m, 3 H),
6.60 (qq, 1 H, J = 7.2, 1.2 Hz), 7.09 (dd, 1 H, J = 4.8, 3.4 Hz), 7.55
(dd, 3 H, J = 3.4, 1.2 Hz), 7.65 (dd, 1 H, J = 4.9, 1.2 Hz).
We thank Ms. Mami Gomibuchi for HRMS analysis.
Synthesis 2003, No. 18, 2882–2885 © Thieme Stuttgart · New York